483
John N. Allan, M.D.John N. Allan, M.D. – FDA 483, Jun 22, 2026
Record Details
An FDA inspection of John N. Allan, M.D., a Sponsor-Investigator in New York, revealed a significant regulatory lapse. The firm failed to submit required annual reports for two Investigational New Drugs (INDs) within the mandated 60-day timeframe following their anniversary dates. This indicates a failure to comply with regulatory reporting requirements for clinical investigations.
- Office
- New York District Office
- Person
View Company Profile
ID · d1f65608-d853-4900-8911-bc4be9c1f640
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.